Wealthcare Advisory Partners LLC Novavax Inc Transaction History

Wealthcare Advisory Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $172,909 - $280,091	-1,285 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $228,473 - $347,695	1,285 New	1,285 $266,000
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $49,247 - $104,871	-407 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$112.98 - $319.93 $45,982 - $130,211	407 New	407 $74,000
Q2 2020 Jul 29, 2020	SELL	$13.86 - $83.61 $11,781 - $71,068	-850 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$3.93 - $16.0 $3,340 - $13,600	850 New	850 $12,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.